Leveraging rapid technological advances for human health is a global trend, driving the rise of biomedical engineering ...

Medical technology companies Senseonics and Ascensia Diabetes Care have announced receipt of the US Food and Drug ...

DexCom, Inc. , the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of the third season of Dexcom U, the company's groundbreaking NIL ...

The U.S. FDA cleared Senseonic Holdings Inc.’s Eversense 365, the first continuous glucose monitor to last a full year with a ...

Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system.

The FDA has cleared Senseonics and Ascensia Diabetes Care's Eversense 365 Glucose Monitoring System. This system is designed for Type 1 and Type 2 diabetics 18 and older and will be the first ...

Senseonics Holdings, Inc. , a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes and ...

A Stourbridge woman who has had type one diabetes for more than 50 years has written a book about her experiences.

Understanding glucose and how your body processes it can provide important personal insights that may help you feel your best ...

The company designs, develops and focuses on commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes. Its products include DexCom G4 PLATINUM System ...

Knowledge of the significance of blood sugar control and the implications of not paying attention to it can assist people in preventing complications.

Abbott's strong innovation pipeline, including advancements in CGM systems, supports its market share gains and growth ...